Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Taskinen

Showing results (211-220 of 318) with videos related to

Pageof 32
Sort By:
Journal of Lipid Research|February 1, 1981
Catabolism of human very low density lipoproteins in vitro: a fluorescent phospholipid method for monitoring lipolysisM R Taskinen, J D Johnson, M L Kashyap, et al.
Diabetes/Metabolism Research and Reviews|February 23, 2005
No acute effect of nateglinide on postprandial lipid and lipoprotein responses in subjects at risk for type 2 diabetesE H Johanson, P-A Jansson, B Gustafson, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 1999
Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a)J Svensson, J O Jansson, M Ottosson, et al.
The Journal of Clinical Investigation|October 1, 1982
Characterization of lipase activities in obese Pima indians. Decreases with weight reductionJ S Reitman, F C Kosmakos, B V Howard, et al.
Journal of Internal Medicine|January 30, 2004
Early alterations in the postprandial VLDL1 apoB-100 and apoB-48 metabolism in men with strong heredity for type 2 diabetesE H Johanson, P-A Jansson, B Gustafson, et al.
European Journal of Clinical Investigation|October 13, 2006
Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery diseaseM Granér, J Kahri, T Nakano, et al.
Diabetes, Obesity & Metabolism|December 1, 2010
Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled studyM-R Taskinen, J Rosenstock, I Tamminen, et al.
Diabetes Care|April 24, 2001
Cardiovascular morbidity and mortality associated with the metabolic syndromeB Isomaa, P Almgren, T Tuomi, et al.
Journal of Lipid Research|March 3, 2004
Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresisD R Witte, M R Taskinen, H Perttunen-Nio, et al.
Diabetologia|August 10, 2011
Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia StudyP Almgren, M Lehtovirta, B Isomaa, et al.
Pageof 32

Showing results (211-220 of 318) with videos related to

Sort By:
Pageof 32
Journal of Lipid Research|February 1, 1981
Catabolism of human very low density lipoproteins in vitro: a fluorescent phospholipid method for monitoring lipolysisM R Taskinen, J D Johnson, M L Kashyap, et al.
Diabetes/Metabolism Research and Reviews|February 23, 2005
No acute effect of nateglinide on postprandial lipid and lipoprotein responses in subjects at risk for type 2 diabetesE H Johanson, P-A Jansson, B Gustafson, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 1999
Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a)J Svensson, J O Jansson, M Ottosson, et al.
The Journal of Clinical Investigation|October 1, 1982
Characterization of lipase activities in obese Pima indians. Decreases with weight reductionJ S Reitman, F C Kosmakos, B V Howard, et al.
Journal of Internal Medicine|January 30, 2004
Early alterations in the postprandial VLDL1 apoB-100 and apoB-48 metabolism in men with strong heredity for type 2 diabetesE H Johanson, P-A Jansson, B Gustafson, et al.
European Journal of Clinical Investigation|October 13, 2006
Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery diseaseM Granér, J Kahri, T Nakano, et al.
Diabetes, Obesity & Metabolism|December 1, 2010
Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled studyM-R Taskinen, J Rosenstock, I Tamminen, et al.
Diabetes Care|April 24, 2001
Cardiovascular morbidity and mortality associated with the metabolic syndromeB Isomaa, P Almgren, T Tuomi, et al.
Journal of Lipid Research|March 3, 2004
Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresisD R Witte, M R Taskinen, H Perttunen-Nio, et al.
Diabetologia|August 10, 2011
Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia StudyP Almgren, M Lehtovirta, B Isomaa, et al.
Pageof 32